Condition: Overweight , Obesity · Sponsor: Beijing QL Biopharmaceutical Co.,Ltd
This study is a single-dose, open-label, parallel design phase I clinical study to evaluate the PK characteristics and safety of single subcutaneous injection of ZT002 Injection in participants with different degrees of renal insufficiency and matched participants with normal renal function.
This description comes directly from the study's public registry record.
Yujie Deng, PhD · +86-010-61702599 · yujie@qlbiopharm.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | Not Yet Recruiting |
| The First Affiliated Hospital Of Shandong First Medical Unversity | Jinan, Shandong, China | Recruiting |
| Sichuan Provincial People's Hospital | Chengdu, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07443059